Evaluating primary suicide prevention in adolescents with risk factors (ESPAIR): study protocol for a cluster-randomized controlled trial.
Stéphanie Baggio, Eleanor Bailey, Anne Edan...
https://pubmed.ncbi.nlm.nih.gov/41286939/Actively Recruiting
Led by Stephanie Baggio · Updated on 2025-12-18
240
Participants Needed
19
Research Sites
69 weeks
Total Duration
Suicide is a leading cause of death among teenagers, and preventing it has become a public health priority. This research aims to evaluate a brief primary suicide prevention intervention specifically for vulnerable adolescents, such as those in juvenile detention, at risk of dropping out of school, undergoing psychiatric treatment, belonging to sexual or gender minorities, affected by chronic conditions, or facing relational or family problems. The study uses a randomized controlled trial to test the interventions impact on suicide awareness, psychological distress, and suicidal thoughts. The intervention being studied is a 90-minute group psychoeducation session conducted by trained staff and a psychologist. It includes lectures, group discussions, and quizzes about suicide facts, myths, risk factors, warning signs, and ways to seek help. Participants are divided into groups of 5 to 15, averaging 10. The control group participates in an art-based workshop focused on slam poetry. After the study, control group participants receive informational flyers about suicide prevention. Participants aged 14 to 25 with good knowledge of French and meeting vulnerability criteria are involved. The study measures outcomes including a composite of suicide awareness one week and three months after the intervention, knowledge of suicide and local resources, suicidal thoughts, psychological distress, and access to suicide prevention. Assessments occur at baseline, one week, and three months post-baseline, with attention to participant retention and safety throughout the study period ending in 2028.
CONDITIONS
Evaluating Primary Suicide Prevention in Adolescents With Risk Factors
S
Stéphanie Baggio, Prof.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Stephanie Baggio
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single session
Participants attend a single 90-minute workshop as part of their assigned intervention: either a psychoeducation session focused on suicide prevention or an art-based slam poetry workshop.
1 visit (in-person)
Duration - 3 months
Participants complete assessments on suicide awareness, knowledge, psychological distress, and suicidal thoughts at one week and three months after the intervention.
2 follow-up visits (in-person or remote) at 1 week and 3 months post-intervention
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Stéphanie Baggio, Eleanor Bailey, Anne Edan...
https://pubmed.ncbi.nlm.nih.gov/41286939/Stephanie Baggio
Lead Sponsor